株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

胎児モニタリングの世界市場:市場分析、企業プロファイル、市場規模、市場シェア、成長、動向、市場予測

Global Fetal Monitoring Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

発行 Data Bridge Market Research Private Limited 商品コード 587844
出版日 ページ情報 英文 350 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.91円で換算しております。
Back to Top
胎児モニタリングの世界市場:市場分析、企業プロファイル、市場規模、市場シェア、成長、動向、市場予測 Global Fetal Monitoring Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
出版日: 2017年10月01日 ページ情報: 英文 350 Pages
概要

当レポートでは、胎児モニタリングの世界市場を調査し、市場の概要、製品・ポータビリティ・侵襲性・用途・エンドユーザー・流通チャネル・地域別の市場動向、市場規模の推移と予測、市場促進要因ならびに市場機会・課題の分析、市場シェア、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

第1章 イントロダクション

第2章 市場区分

  • 重要点
  • 市場規模
    • 企業の収益額・市場シェアの分析
    • 三角測量法
    • 1次情報源から得たデータ・論点
    • 2次情報源から得たデータ・論点
    • ファイブフォース分析
    • PEST分析
    • 患者数予測モデル
  • 調査概要
  • 前提条件

第3章 市場概要

  • 市場促進要因
  • 市場阻害要因
  • 市場機会
  • 課題

第4章 エグゼクティブサマリー

第5章 重要考察

第6章 胎児モニタリングの世界市場:製品別

  • 市場概要
  • モニタリング装置・消耗品
    • 超音波モニター
    • 母体/胎児電子モニター
    • 児頭電極
    • 胎児ドップラー
    • 分娩監視モニター
    • テレメトリー
    • 付属品・消耗品
    • その他
  • ソフトウェア

第7章 胎児モニタリングの世界市場:ポータビリティ別

  • 市場概要
  • 一体型システム
  • ポータブルシステム
  • ウェアラブルシステム

第8章 胎児モニタリングの世界市場:侵襲性別

  • 市場概要
  • 非侵襲的モニタリング
  • 侵襲的モニタリング

第9章 胎児モニタリングの世界市場:用途別

  • 市場概要
  • 分娩前胎児モニタリング
  • 分娩時胎児モニタリング

第10章 胎児モニタリングの世界市場:エンドユーザー別

  • 市場概要
  • 病院
  • 産科・婦人科
  • 在宅ケア

第11章 胎児モニタリングの世界市場:流通チャネル別

  • 市場概要
  • 直接入札
  • 小売

第12章 胎児モニタリングの世界市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
  • 主要国の分析

第13章 競合環境

  • 企業の市場シェア:地域別
  • 合併・買収
  • 新製品の開発・承認
  • 事業拡大
  • 規制環境の変化
  • パートナーシップ・その他の戦略動向

第14章 企業プロファイル

  • ANALOGIC CORPORATION
  • FUJIFILM SONOSITE, INC.
  • GE HEALTHCARE
  • PHILIPS HEALTHCARE
  • SIEMENS HEALTHCARE
  • COVIDIEN PLC
  • ARJOHUNTLEIGH
  • NEOVENTA MEDICAL AB
  • BRIGGS HEALTHCARE
  • NATUS MEDICAL INCORPORATED
  • SPACELABS HEALTHCARE
  • EDAN INSTRUMENTS, INC.
  • COOPERSURGICAL INC.
  • NEOVENTA MEDICAL AB
  • MEDTRONIC PLC

第15章 付録

第16章 Data Bridge Market Researchについて

目次

Title:
Global Fetal Monitoring Market
By Product Type (Instruments & Consumables {Ultrasound (2D Ultrasound, 3D & 4D Ultrasound), Electronic Maternal/Fetal Monitor (External Monitor, Internal Monitors), Fetal Electrodes, Fetal Doppler, Telemetry Solutions, Accessories & Consumables}, Software), By Portability {Standalone Systems, Portable Systems (Wearable Systems, Non-Wearable Systems)}, By Methods (Non-Invasive, Invasive), By Application (Antepartum, Intrapartum), By End User (Hospitals, Gynecological/Obstetrics Clinics, Homecare, Others), By Distribution Channel (Direct Tender, Retail), By Region (North America, Europe, Asia-Pacific, South America and Middle East & Africa) - Industry Trends and Forecast to 2024.

Global Fetal Monitoring Market is expected to reach USD 3,245.49 million by 2024 from USD 1,954.00 million in 2016, at a CAGR of 6.7% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the increasing birth rates and preterm births, technological advancements and new product launch, government and non-government funds for the best facilities.

The key market players for Global Fetal Monitoring Market are listed below:

  • Koninklijke Philips N.V.,
  • Fujifilm Holding Corporation and Siemens
  • Edan Instruments Inc.,
  • Neoventa Medical AB,
  • Medtronic,
  • Natus Medical incorporated,
  • Cooper Companies, Inc.,
  • MedGyn Products Inc.,
  • Dixion, Lutech Industries Inc,
  • Advanced Instruments, Inc,
  • Shenzhen Bestman Instrument Co., Ltd.,
  • TRISMED Co., LTD,
  • Progetti Srl,
  • ArjoHuntleigh,
  • Analogic Corporation,
  • Wallach Surgical Devices,
  • OSI System Inc.

The market is further segmented into:

  • Type
  • Material
  • End User
  • Geography

The global fetal monitoring market is segmented on the basis of product type, portability, methods, application, end users and distribution channel. Based on product type, the global fetal monitoring market is segmented into instruments & consumables and software.

On the basis of portability, the global fetal monitoring market is segmented into standalone systems and portable systems. Portable systems are further sub segmented into wearable systems and non-wearable systems. In 2017, the standalone segment is expected to dominate the market with 70.3% market share.

On the basis of methods, the global fetal monitoring market is segmented into non-invasive method and invasive method.

By application, the global fetal monitoring market is segmented into antepartum fetal monitoring and intrapartum fetal monitoring. Antepartum is the most common and the highest growing segment with the highest CAGR of 7.6% in the forecast period 2017 to 2024.

On the basis of end users, the global fetal monitoring market is classified into hospitals, gynecological/obstetrics clinics, homecare and others. Among these, in 2017 hospitals segment dominated the market and the trend is expected to remain the same till 2024.

On the basis of distribution channel, the global fetal monitoring market is classified into direct tender and retail. Among these, in 2017 direct tender segment dominated the market and the trend is expected to remain the same till 2024.

Based on geography, the Global Fetal Monitoring market is segmented into geographical regions, such as,

  • North America,
  • Europe,
  • Asia-Pacific,
  • South America
  • Middle East & Africa

Covered in this report:

The report covers the present scenario and the growth prospects of the Global Fetal Monitoring market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE GLOBAL FETAL MONITORING MARKET
  • 1.2. CURRENCY AND PRICING
  • 1.3. LIMITATION
  • 1.4. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL FETAL MONITORING MARKET SIZE
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6. PORTER'S FIVE FORCES MATRIX
    • 2.2.7. PEST ANALYSIS
    • 2.2.8. EPIDEMIOLOGY FORECASTING MODELS
  • 2.3. GLOBAL FETAL MONITORING MARKET: RESEARCH SNAPSHOT
  • 2.4. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
  • 3.2. RESTRAINTS
  • 3.3. OPPORTUNITIES
  • 3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL FETAL MONITORING MARKET, BY PRODUCT

  • 6.1. OVERVIEW
  • 6.2. INSTRUMENTS & CONSUMABLES
    • 6.2.1. ULTRASOUND
      • 6.2.1.1. 2D ULTRASOUND
      • 6.2.1.2. 3D & 4D ULTRASOUND
      • 6.2.1.3. DOPPLER IMAGING
    • 6.2.2. ELECTRONIC MATERNAL/FETAL MONITOR
      • 6.2.2.1. EXTERNAL MONITOR
      • 6.2.2.2. OTHER MONITORS
    • 6.2.3. FETAL ELECTRODES
      • 6.2.3.1. DIGITAL BLOOD PRESSURE MONITORS
      • 6.2.3.2. ANEROID BLOOD PRESSURE MONITORS
      • 6.2.3.3. WEARABLE BLOOD PRESSURE MONITORS
    • 6.2.4. FETAL DOPPLER
    • 6.2.5. UTERINE CONTRACTION MONITOR
      • 6.2.3.1. EXTERNAL MONITORING
      • 6.2.3.2. INTERNAL MONITORING
    • 6.2.6. TELEMETRY SOLUTIONS
    • 6.2.7. ACCESSORIES & CONSUMABLES
    • 6.2.8. OTHER PRODUCTS
  • 6.3. SOFTWARE

7. GLOBAL FETAL MONITORING MARKET, BY PORTABILITY

  • 7.1. OVERVIEW
  • 7.2. STANDALONE SYSTEMS
  • 7.3. PORTABLE SYSTEMS
  • 7.4. WEARABLE SYSTEMS

8. GLOBAL FETAL MONITORING MARKET, BY METHOD

  • 8.1. OVERVIEW
  • 8.2. NON-INVASIVE
  • 8.3. INVASIVE

9. GLOBAL FETAL MONITORING MARKET, BY APPLICATION

  • 9.1. OVERVIEW
  • 9.2. ANTEPARTUM FETAL MONITORING
  • 9.3. INTRAPARTUM FETAL MONITORING

10. GLOBAL FETAL MONITORING MARKET, BY END USER

  • 10.1. OVERVIEW
  • 10.2. HOSPITALS
  • 10.3. GYNECOLOGICAL/OBSTETRICS CLINICS
  • 10.4. HOMECARE
  • 10.5. OTHERS

11. GLOBAL FETAL MONITORING MARKET, BY DISTRIBUTION CHANNEL

  • 11.1. OVERVIEW
  • 11.2. DIRECT TENDER
  • 11.3. RETAIL 

12. GLOBAL FETAL MONITORING MARKET, BY COUNTRY

  • 12.1. COUNTRYWISE GLOBAL FETAL MONITORING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • 12.1.1. NORTH AMERICA
      • 12.1.1.1. U.S.
      • 12.1.1.2. CANADA
      • 12.1.1.3. MEXICO
    • 12.1.2. EUROPE
      • 12.1.2.1. GERMANY
      • 12.1.2.2. FRANCE
      • 12.1.2.3. U.K.
      • 12.1.2.4. ITALY
      • 12.1.2.5. SPAIN
      • 12.1.2.6. RUSSIA
      • 12.1.2.7. TURKEY
      • 12.1.2.8. BELGIUM
      • 12.1.2.9. NETHERLANDS
      • 12.1.2.10. SWITZERLAND
      • 12.1.2.11. REST OF EUROPE
    • 12.1.3. ASIA-PACIFIC (APAC)
      • 12.1.3.1. JAPAN
      • 12.1.3.2. CHINA
      • 12.1.3.3. SOUTH KOREA
      • 12.1.3.4. INDIA
      • 12.1.3.5. AUSTRALIA
      • 12.1.3.6. SINGAPORE
      • 12.1.3.7. THAILAND
      • 12.1.3.8. MALAYSIA
      • 12.1.3.9. INDONESIA
      • 12.1.3.10. PHILIPPINES
      • 12.1.3.11. REST OF APAC
    • 12.1.4. LATIN AMERICA
      • 12.1.4.1. BRAZIL
      • 12.1.4.2. REST OF LATIN AMERICA
    • 12.1.5. MIDDLE EAST AND AFRICA
      • 12.1.5.1. SOUTH AFRICA
      • 12.1.5.2. REST OF MIDDLE EAST AND AFRICA
  • 12.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

13. GLOBAL FETAL MONITORING MARKET: COMPETITIVE LANDSCAPE

  • 13.1. GLOBAL FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS

13.2. NORTH AMERICA FETAL MONITORING MARKET:

COMPANY SHARE ANALYSIS

  • 13.3. EUROPE FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.4. APAC FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.5. MEA FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.6. SOUTH AMERICA FETAL MONITORING MARKET: COMPANY SHARE ANALYSIS
  • 13.7. MERGERS & ACQUISITIONS
  • 13.8. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 13.9. EXPANSIONS
  • 13.10. REGULATORY CHANGES
  • 13.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

14. GLOBAL FETAL MONITORING MARKET, COMPANY PROFILES

  • 14.1. ANALOGIC CORPORATION
    • 14.1.1. COMPANY OVERVIEW
    • 14.1.2. FINANCIAL ANALYSIS
    • 14.1.3. PRODUCT MATRIX
    • 14.1.4. RECENT DEVELOPMENTS
    • 14.1.5. DATABRIDGE ANALYSIS
  • 14.2. FUJIFILM SONOSITE, INC.
    • 14.2.1. COMPANY OVERVIEW
    • 14.2.2. FINANCIAL ANALYSIS
    • 14.2.3. PRODUCT MATRIX
    • 14.2.4. RECENT DEVELOPMENTS
    • 14.2.5. DATABRIDGE ANALYSIS
  • 14.3. GE HEALTHCARE
    • 14.3.1. COMPANY OVERVIEW
    • 14.3.2. FINANCIAL ANALYSIS
    • 14.3.3. PRODUCT MATRIX
    • 14.3.4. RECENT DEVELOPMENTS
    • 14.3.5. DATABRIDGE ANALYSIS
  • 14.4. PHILIPS HEALTHCARE
    • 14.4.1. COMPANY OVERVIEW
    • 14.4.2. FINANCIAL ANALYSIS
    • 14.4.3. PRODUCT MATRIX
    • 14.4.4. RECENT DEVELOPMENTS
    • 14.4.5. DATABRIDGE ANALYSIS
  • 14.5. SIEMENS HEALTHCARE
    • 14.5.1. COMPANY OVERVIEW
    • 14.5.2. FINANCIAL ANALYSIS
    • 14.5.3. PRODUCT MATRIX
    • 14.5.4. RECENT DEVELOPMENTS
    • 14.5.5. DATABRIDGE ANALYSIS
  • 14.6. COVIDIEN PLC
    • 14.6.1. COMPANY OVERVIEW
    • 14.6.2. FINANCIAL ANALYSIS
    • 14.6.3. PRODUCT MATRIX
    • 14.6.4. RECENT DEVELOPMENTS
    • 14.6.5. DATABRIDGE ANALYSIS
  • 14.7. ARJOHUNTLEIGH
    • 14.7.1. COMPANY OVERVIEW
    • 14.7.2. FINANCIAL ANALYSIS
    • 14.7.3. PRODUCT MATRIX
    • 14.7.4. RECENT DEVELOPMENTS
    • 14.7.5. DATABRIDGE ANALYSIS
  • 14.8. NEOVENTA MEDICAL AB
    • 14.8.1. COMPANY OVERVIEW
    • 14.8.2. FINANCIAL ANALYSIS
    • 14.8.3. PRODUCT MATRIX
    • 14.8.4. RECENT DEVELOPMENTS
    • 14.8.5. DATABRIDGE ANALYSIS
  • 14.9. BRIGGS HEALTHCARE
    • 14.9.1. COMPANY OVERVIEW
    • 14.9.2. FINANCIAL ANALYSIS
    • 14.9.3. PRODUCT MATRIX
    • 14.9.4. RECENT DEVELOPMENTS
    • 14.9.5. DATABRIDGE ANALYSIS

  • 14.10. NATUS MEDICAL INCORPORATED
    • 14.10.1. COMPANY OVERVIEW
    • 14.10.2. FINANCIAL ANALYSIS
    • 14.10.3. PRODUCT MATRIX
    • 14.10.4. RECENT DEVELOPMENTS
    • 14.10.5. DATABRIDGE ANALYSIS
  • 14.11. SPACELABS HEALTHCARE
    • 14.11.1. COMPANY OVERVIEW
    • 14.11.2. FINANCIAL ANALYSIS
    • 14.11.3. PRODUCT MATRIX
    • 14.11.4. RECENT DEVELOPMENTS
    • 14.11.5. DATABRIDGE ANALYSIS
  • 14.12. EDAN INSTRUMENTS, INC.
    • 14.12.1. COMPANY OVERVIEW
    • 14.12.2. FINANCIAL ANALYSIS
    • 14.12.3. PRODUCT MATRIX
    • 14.12.4. RECENT DEVELOPMENTS
    • 14.12.5. DATABRIDGE ANALYSIS
  • 14.13. COOPERSURGICAL INC.
    • 14.13.1. COMPANY OVERVIEW
    • 14.13.2. FINANCIAL ANALYSIS
    • 14.13.3. PRODUCT MATRIX
    • 14.13.4. RECENT DEVELOPMENTS
    • 14.13.5. DATABRIDGE ANALYSIS
  • 14.14. NEOVENTA MEDICAL AB
    • 14.14.1. COMPANY OVERVIEW
    • 14.14.2. FINANCIAL ANALYSIS
    • 14.14.3. PRODUCT MATRIX
    • 14.14.4. RECENT DEVELOPMENTS
    • 14.14.5. DATABRIDGE ANALYSIS
  • 14.15. MEDTRONIC PLC
    • 14.15.1. COMPANY OVERVIEW
    • 14.15.2. FINANCIAL ANALYSIS
    • 14.15.3. PRODUCT MATRIX
    • 14.15.4. RECENT DEVELOPMENTS
    • 14.15.5. DATABRIDGE ANALYSIS

15. APPENDIX

16. ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top